- In March 2021, Corbion announced that the company has decided to boost the lactic acid production capacity through a series of concurrent expansion projects. This will increase the market for Corbion and will add up the revenue of the company in the forecasted period
- In October 2020, Viatris Inc a combined company of Mylan and Pfizer Inc. received clearance from U.S Federal Trade Commission. This approval paved the way for the establishment of new company having great emphasis on development of innovative medicines and breakthrough in order to change patient’s lives. This approval unlocked the future for company growth
- In September 2020, Viatris Inc, a combined company of Mylan and Pfizer Inc. received EU approval. Moreover, the company also achieved approval from Australian competition, consumer commission, and New Zealand commission that have strengthened its proposal of company establishment. This approval allowed the company launches new company that is positioned to meet patients need
